We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App


31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Detachable Cardiac Pacing Lead to Improve Safety for Heart Patients

By HospiMedica International staff writers
Posted on 03 Jul 2024
Print article
Image: Pacing leads are routinely used to monitor patients and protect against the risk of postoperative arrhythmias (Photo courtesy of MIT)
Image: Pacing leads are routinely used to monitor patients and protect against the risk of postoperative arrhythmias (Photo courtesy of MIT)

Bypass surgery ranks as one of the most frequent open-heart surgeries, with the risk of mortality now nearly negligible. Nonetheless, there are instances where the removal of temporary cardiac pacing leads results in fatal heart damage. These pacing leads are typically employed during the post-surgical recovery phase to monitor patients and mitigate the risk of postoperative arrhythmias, such as complete heart blockages. The existing procedures for lead placement, involving surgical stitches or direct electrode insertion into the heart tissue, can cause trauma during both the insertion and removal processes. This increases the likelihood of tissue damage, bleeding, and device malfunction. Now, new research, published in the journal Science Translational Medicine, has demonstrated findings that could offer a potential platform for adhesive bioelectronic devices for cardiac monitoring, diagnosis, and treatment, and pave the way for the future development of bioadhesive electronics.

A team from the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA) has introduced a 3D-printable bioadhesive pacing lead that can directly interface with heart tissue, facilitating minimally invasive adhesive implantation and offering an easy detachment method for gentle removal. This innovation represents the first bioadhesive version of a temporary cardiac pacing lead that can be attached and detached on-demand, improving safety and bioelectronic performance with a trauma-free application and removal process. The development of this bioadhesive pacing lead merges several technologies previously developed by the team in the fields of bioadhesives, bioelectronics, and 3D printing.

The MIT researchers developed 3D-printable bioadhesive materials by graft-polymerizing polyacrylic acid on hydrophilic polyurethane and mixing with poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) (PEDOT:PSS) to enhance electrical conductivity. The resulting bioadhesive showed mechanical properties comparable to cardiac tissue and demonstrated strong adherence, ensuring stable electrical connectivity. In experimental studies using rat and porcine models, the bioadhesive pacing lead adhered solidly to cardiac tissue without causing visible tissue damage or bleeding during application or on-demand detachment. The device was compatible with standard clinical pacing systems and maintained a reliable electrical connection for cardiac monitoring and pacing over a period of 10 to 14 days in the animal models. These findings validate the potential of using printable adhesive electronics for cardiac pacing applications.

Related Links:

Gold Member
12-Channel ECG
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
Hydraulic Surgical Stool

Print article


Critical Care

view channel
Image: A visualization of the blood-brain barrier disruption one hour post-treatment as noted by the diffusion of normally impermeant (Photo courtesy of APL Bioengineering)

New Technique Treats Aggressive Brain Tumors by Disrupting Blood-Brain Barrier

Glioblastoma, the most common malignant brain tumor, accounts for more than half of all such cancers. Despite the use of aggressive treatments like surgery, chemotherapy, and radiotherapy, the prognosis... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more


view channel
Image: The finalists have been announced for the IHF Awards 2024 (Photo courtesy of IHF)

International Hospital Federation Awards 2024 Finalists Announced

The International Hospital Federation (IHF; Geneva, Switzerland) has announced the finalists of the IHF Awards 2024 after the judges completed scoring entries in all 7 Award categories. The IHF Awards... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.